Stay updated with breaking news from Opgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JPMorgan Chase & Co. started coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a report released on Tuesday morning, The Fly reports. The brokerage issued a neutral rating on the biotechnology company’s stock. PGEN has been the subject of a number of other research reports. HC Wainwright reaffirmed a buy rating and issued […]
JPMorgan Chase & Co. started coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a research report sent to investors on Tuesday morning, The Fly reports. The brokerage issued a neutral rating on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on the stock. StockNews.com started coverage on […]
Investment analysts at JPMorgan Chase & Co. initiated coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage set a “neutral” rating on the biotechnology company’s stock. A number of other equities analysts have also issued reports on PGEN. HC […]
OpGen, Inc. (NASDAQ:OPGN – Get Rating) – Analysts at Edison Inv. Res issued their FY2023 earnings estimates for OpGen in a note issued to investors on Wednesday, May 17th. Edison Inv. Res analyst A. Aatkar forecasts that the medical research company will earn ($3.39) per share for the year. The consensus estimate for OpGen’s current […]
StockNews.com upgraded shares of OpGen (NASDAQ:OPGN – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday. OpGen Stock Up 7.9 % OPGN stock opened at $0.75 on Tuesday. The company has a quick ratio of 0.88, a current ratio of 1.24 and a debt-to-equity ratio of 0.58. The […]